I am Professor in Tissue Repair, based at Cardiff University (UK). I graduated from Swansea University (UK), with a BSc (Hons.) Degree in Biochemistry. I obtained my PhD from the School of Dentistry, University of Wales College of Medicine (UK), examining the role of oxidative stress in periodontal disease. I now have > 34 years research experience at Cardiff University, specialising in the mechanisms underlying cellular wound healing responses in oral (bone, oral mucosa, gingiva) and dermal (normal skin, chronic skin wounds, fibrotic skin) tissues during health and disease. By understanding these mechanisms, my Research Group develops novel pharmaceutical and other strategies to promote healing and improved wound management in these patients. I have successfully managed numerous projects in these areas, supported by non-commercial and commercial funding sources worldwide, including the MRC, BBSRC, NHMRC (Australia), Wellcome Trust, and Dunhill Medical Trust (Vivensa), in addition to industrial partners including Convatec Wound Care, Johnson and Johnson Wound Management, Peplin Inc. (now LEO Pharma), QBiotics Group, Phillips Research, Cultech, and Copner Biotech. My research has culminated in numerous peer-reviewed publications, filed patents with industrial and academic partners in the dermal wound healing sector; and many conference prizes. Professor Moseley is a current elected member of the European Tissue Repair Society (ETRS) and a Past Secretary of the Society.